H35.389
Toxic maculopathy, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Toxic maculopathy is a condition characterized by damage to the macula, the central part of the retina responsible for sharp vision, caused by exposure to toxic substances. This disorder can lead to visual disturbances and potentially impair daily activities. Although the exact cause of toxic maculopathy often varies, it typically results from exposure to harmful chemicals or medications that adversely affect the eye's delicate tissues. Proper understanding and early detection are key to managing the condition and preventing irreversible vision loss.
Causes & Symptoms
Clinical Causes: Exposure to certain systemic medications (e.g., chloroquine, hydroxychloroquine, thioridazine), especially when used over long periods. Inhalation or contact with toxic chemicals or fumes, such as solvents, pesticides, or industrial chemicals. Use of eye-damaging substances like methanol, which can directly harm the retinal tissues. Accidental or environmental exposure to toxins that can reach the eye and cause localized damage. Underlying metabolic or systemic illnesses that predispose the retina to toxicity. Prolonged use of high-dose vitamin A or other supplements that may have toxic effects on the eye.
Key Symptoms: Gradual or sudden decrease in visual acuity, especially in the central vision. Presence of a dark or blurred spot in the central vision field. Difficulty in seeing fine details or reading small print. Color vision changes, such as dullness or distorted perception of colors. Perception of a blind spot (scotoma) in the central visual field. Potential visual distortion or metamorphopsia, where straight lines appear wavy. In some cases, no obvious symptoms until significant damage has occurred.
Diagnostic & Treatment
Diagnosis Path: Diagnosing toxic maculopathy involves a comprehensive eye examination, including visual acuity testing and detailed retinal assessment. Additional diagnostic tools include:
Treatment Protocols: Managing toxic maculopathy primarily focuses on eliminating or reducing the exposure to the toxic agent. Specific approaches include:
Clinical Advice & FAQs
Billing Guidance
Is H35.389 a billable ICD-10 code?
Yes, H35.389 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.389?
Clinical documentation must specify the nature of Toxic maculopathy, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference